We are live on ! Find out more
TCRR

TCR2 Therapeutics Inc. Common Stock
TCRR

Delisted

TCRR was delisted on the 31st of May, 2023.

Back to rankings

94 hedge funds and large institutions have $74.8M invested in TCR2 Therapeutics Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 36 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

23% less funds holding

Funds holding: 122 → 94 (-28)

33% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 36

45% less capital invested

Capital invested by funds: $136M → $74.8M (-$61.2M)

66% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 41

90% less call options, than puts

Call options by funds: $7K | Put options by funds: $69K

Holders
94
Holders Change
-28
Holders Change %
-22.95%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
24
Reduced
36
Closed
41
Calls
$7K
Puts
$69K
Net Calls
-$62K
Net Calls Change
+$103K

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$9.44M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.73M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.46M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.13M
5
Prudential Financial
Prudential Financial
New Jersey
+$781K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.23M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.89M
3
Bank of America
Bank of America
North Carolina
-$3.19M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.63M
5
PPA
Parametric Portfolio Associates
Washington
-$1.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
XSC
51
X-Square Capital
Puerto Rico
$88K – – –
SS
52
Simplicity Solutions
Minnesota
$87K +$99.2K +31,530 New
JMPWA
53
JP Morgan Private Wealth Advisors
California
$71K – – –
AllianceBernstein
54
AllianceBernstein
Tennessee
$61K -$16K -5,100 -19%
HSBC Holdings
55
HSBC Holdings
United Kingdom
$53K – – –
Deutsche Bank
56
Deutsche Bank
Germany
$53K +$1.45K +461 +2%
NFGH
57
Nan Fung Group Holdings
Hong Kong
$53K +$60.8K +19,335 New
State Board of Administration of Florida Retirement System
58
State Board of Administration of Florida Retirement System
Florida
$51K – – –
Federated Hermes
59
Federated Hermes
Pennsylvania
$43K +$30.9K +9,818 +167%
AIG
60
American International Group
New York
$42K -$3.36K -1,067 -7%
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$38K – – –
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$37K -$9.84K -3,127 -19%
IFG
63
Independent Financial Group
California
$33.1K -$629 -200 -2%
Wells Fargo
64
Wells Fargo
California
$32K -$33.6K -10,689 -48%
GC
65
Guggenheim Capital
Illinois
$31K -$107 -34 -0.3%
BCM
66
Bayesian Capital Management
New York
$31K +$35.5K +11,300 New
VOYA Investment Management
67
VOYA Investment Management
Georgia
$30K – – –
TRCT
68
Tower Research Capital (TRC)
New York
$27K -$24.4K -7,742 -44%
AB
69
Amalgamated Bank
New York
$10K +$11.6K +3,672 New
AF
70
Amalgamated Financial
New York
$10K +$11.6K +3,672 New
LC
71
Lindbrook Capital
California
$8K – – –
Legal & General Group
72
Legal & General Group
United Kingdom
$7K – – –
Citigroup
73
Citigroup
New York
$6K -$21.2K -6,734 -76%
PHK
74
Point72 Hong Kong
Hong Kong
$6K -$16.6K -5,288 -70%
AIP
75
Ameritas Investment Partners
Nebraska
$6K – – –
1 2
3
4 5

TCRR Hedge Fund Activity: Q1 2022 in Review

94 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in TCR2 Therapeutics Inc. Common Stock (TCRR) for Q1 2022, worth a combined $74.8M — down 45% from $136M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of TCRR and 14 opened new positions — a net loss of 27 holders — while 36 trimmed existing stakes and 24 added.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $9.44M. The largest seller was Millennium Management, cutting an estimated $4.23M.

  • 94 institutional investors held TCR2 Therapeutics Inc. Common Stock (TCRR) as of Q1 2022, down from 122 in Q4 2021.
  • Funds reported $74.8M of TCR2 Therapeutics Inc. Common Stock stock for Q1 2022, down 45% quarter-over-quarter.
  • 14 funds opened new TCR2 Therapeutics Inc. Common Stock positions in Q1 2022 and 41 closed out, a net change of -27 holders.
  • The largest TCR2 Therapeutics Inc. Common Stock buyer in Q1 2022 was Tang Capital Management, an estimated $9.44M added.
  • The largest TCR2 Therapeutics Inc. Common Stock seller in Q1 2022 was Millennium Management, an estimated $4.23M sold.

Based on aggregated 13F filings for Q1 2022.